ArticleJournal for immunotherapy of cancer2019
Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy.
Paola Dama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
71 papers cite itlatest 60 shown
this paperpooled itcites it